|
|
|
|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The PRIMA Trial is a clinical study designed to evaluate the effectiveness of PFO closure for migraine. PFO closure is performed by placing an occlusion device into the PFO through a catheter in a catheterization laboratory setting.
The trial will measure and compare headache frequency and severity from those who receive PFO closure to those who do not. Approximately 144 patients will be randomized in the PRIMA Trial at approximately 20 sites in the EU, Switzerland and Canada. |
DO I QUALIFY FOR INCLUSION IN THE PRIMA TRIAL? There are a number of criteria that you must meet to be part of the trial, and a number of factors in your health history that might prevent you from being a participant. You can answer a short list of questions to see if you might qualify to participate in the PRIMA Trial or Contact Us using the telephone numbers below. 
CONTACT US
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal blood flow through the